|
Current issue
Archive
Online First
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
Open access 
|
6/2007
vol. 6 abstract:
MMAC/PTEN gene expression in endometrial cancer – RT-PCR studies
Anna Sobczuk
,
Hanna Romanowicz-Makowska
,
Tomasz Pertyński
Przegląd Menopauzalny 2007; 6: 344-346
Online publish date: 2007/12/19
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Mutations in the MMAC/PTEN (phosphatase and tensin homologue deleted on chromosome 10) gene are documented in cancers of the breast, prostate, ovary, colon, melanoma, glioblastoma, lymphoma and endometrium.
In the present work MMAC/PTEN gene expression in women with endometrial adenocarcinoma (n=70) in RNA samples obtained from cancer tissue were investigated. Control DNA was obtained from 68 normal endometrial tissue samples. The MMAC/PTEN expression was determined by RT-PCR analysis. Expression of the MMAC/PTEN gene in endometrial adenocarcinoma cases was significantly reduced compared to the expression in the normal samples (p<0.05). Furthermore a significant difference (p<0.05) was observed between the expression of MMAC/PTEN in stage III versus lower stages of endometrial cancer. The results support the hypothesis that MMAC/PTEN gene expression may be associated with the incidence of endometrial cancer. keywords:
MMAC/PTEN, expression, sporadic endometrial cancer, RT-PCR |
 |
